Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Schizophrenia

  Free Subscription


Articles published in J Clin Psychopharmacol

Retrieve available abstracts of 54 articles:
HTML format
Text format



Single Articles


    January 2019
  1. IVKOVIC J, Lindsten A, George V, Eriksson H, et al
    Effect of Brexpiprazole on Prolactin: An Analysis of Short- and Long-Term Studies in Schizophrenia.
    J Clin Psychopharmacol. 2019;39:13-19.
    PubMed     Text format     Abstract available


    October 2018
  2. SUZUKI H, Hibino H, Inoue Y, Takaya A, et al
    Treatment Continuation of 3 Second-Generation Antipsychotic Long-Acting Injections, and Oral Paliperidone in Patients With Schizophrenia for 2 Years.
    J Clin Psychopharmacol. 2018 Oct 16. doi: 10.1097/JCP.0000000000000976.
    PubMed     Text format    


  3. TANI H, Suzuki T, Wolfgang Fleischhacker W, Tomita M, et al
    Clinical Characteristics of Patients With Schizophrenia Who Successfully Discontinued Antipsychotics: A Literature Review.
    J Clin Psychopharmacol. 2018 Oct 8. doi: 10.1097/JCP.0000000000000959.
    PubMed     Text format     Abstract available


    September 2018
  4. KAKUNJE A, Prabhu A, Priya Es S, Karkal R, et al
    Acetazolamide for Antipsychotic-Associated Weight Gain in Schizophrenia.
    J Clin Psychopharmacol. 2018 Sep 6. doi: 10.1097/JCP.0000000000000940.
    PubMed     Text format    


    August 2018
  5. DIEFENDERFER LA, Lang SE, Patel M
    Successful Treatment of Delusional Disorder With Aripiprazole Long-Acting Injection.
    J Clin Psychopharmacol. 2018;38:400-402.
    PubMed     Text format    


  6. GONZALEZ-RODRIGUEZ A, Estrada F, Monreal JA, Palao D, et al
    A Systematic Review of Methods for the Measurement of Antipsychotic Adherence in Delusional Disorder.
    J Clin Psychopharmacol. 2018;38:412-414.
    PubMed     Text format    


    July 2018
  7. HARD ML, Wehr AY, Du Y, Weiden PJ, et al
    Pharmacokinetic Evaluation of a 1-Day Treatment Initiation Option for Starting Long-Acting Aripiprazole Lauroxil for Schizophrenia.
    J Clin Psychopharmacol. 2018 Jul 13. doi: 10.1097/JCP.0000000000000921.
    PubMed     Text format     Abstract available


    June 2018
  8. KELLY DL, Powell MM, Wehring HJ, Sayer MA, et al
    Adjunct Aripiprazole Reduces Prolactin and Prolactin-Related Adverse Effects in Premenopausal Women With Psychosis: Results From the DAAMSEL Clinical Trial.
    J Clin Psychopharmacol. 2018 Jun 15. doi: 10.1097/JCP.0000000000000898.
    PubMed     Text format     Abstract available


  9. ENGLISCH S, Jung HS, Eisenacher S, Lewien A, et al
    Neurocognitive Effects of Agomelatine Treatment in Schizophrenia Patients Suffering From Comorbid Depression: Results From the AGOPSYCH Study.
    J Clin Psychopharmacol. 2018 Jun 14. doi: 10.1097/JCP.0000000000000909.
    PubMed     Text format     Abstract available


  10. BALLON JS, Ashfaq H, Noordsy DL
    Clozapine Titration for People in Early Psychosis: A Chart Review and Treatment Guideline.
    J Clin Psychopharmacol. 2018;38:234-238.
    PubMed     Text format     Abstract available


  11. SOLISMAA A, Kampman O, Lyytikainen LP, Seppala N, et al
    Genetic Polymorphisms Associated With Constipation and Anticholinergic Symptoms in Patients Receiving Clozapine.
    J Clin Psychopharmacol. 2018;38:193-199.
    PubMed     Text format     Abstract available


  12. HELLAND A, Habib S, Ulvestad L, Spigset O, et al
    Systemic Inflammation Complicates the Interpretation of Therapeutic Drug Monitoring of Risperidone.
    J Clin Psychopharmacol. 2018;38:263-265.
    PubMed     Text format    


    April 2018
  13. GAUDIANO BA, Guzman Holst C, Morena A, Reeves LE, et al
    Complex Polypharmacy in Patients With Schizophrenia-Spectrum Disorders Before a Psychiatric Hospitalization: Prescribing Patterns and Associated Clinical Features.
    J Clin Psychopharmacol. 2018 Apr 3. doi: 10.1097/JCP.0000000000000876.
    PubMed     Text format     Abstract available


  14. BOTILLO-MARTIN C, Gonzalez-Pablos E
    Rhabdomyolysis of Multifactorial Origin in Schizophrenia: Antipsychotics, Statins, Trauma.
    J Clin Psychopharmacol. 2018 Apr 2. doi: 10.1097/JCP.0000000000000880.
    PubMed     Text format    


  15. SAVULICH G, Mezquida G, Atkinson S, Bernardo M, et al
    A Case Study of Clozapine and Cognition: Friend or Foe?
    J Clin Psychopharmacol. 2018;38:152-153.
    PubMed     Text format    


    March 2018
  16. JONES C
    alpha7 Nicotinic Acetylcholine Receptor: A Potential Target in Treating Cognitive Decline in Schizophrenia.
    J Clin Psychopharmacol. 2018 Mar 2. doi: 10.1097/JCP.0000000000000859.
    PubMed     Text format     Abstract available


    February 2018
  17. HAJI SEYED JAVADI A, Shafikhani AA, Zamir SM, Khanshir ZF, et al
    Evaluation of the Effect of Fluvoxamine in Patients With Schizophrenia Under Risperidone Treatment: A Clinical Trial.
    J Clin Psychopharmacol. 2018 Feb 9. doi: 10.1097/JCP.0000000000000850.
    PubMed     Text format     Abstract available


  18. LIU F, Xie L, Zhang B, Ruan Y, et al
    No Effect of Adjunctive Minocycline Treatment on Body Metabolism in Patients With Schizophrenia.
    J Clin Psychopharmacol. 2018 Feb 8. doi: 10.1097/JCP.0000000000000841.
    PubMed     Text format     Abstract available


  19. ZHAI D, Liu Y, Ma F, Feng Y, et al
    Effects of the First Exposure of Antipsychotics on Serum Albumin in Adolescents and Young Adults With First-Episode Schizophrenia.
    J Clin Psychopharmacol. 2018;38:103-105.
    PubMed     Text format    


  20. SAPRA M, Lawson D, Iranmanesh A
    Fat Distribution in Schizophrenia Patients: A Pilot Study Comparing First- and Second-Generation Antipsychotics.
    J Clin Psychopharmacol. 2018;38:68-71.
    PubMed     Text format     Abstract available


  21. ZHAO MJ, Qin B, Wang JB, Zhang YP, et al
    Efficacy and Acceptability of Cariprazine in Acute Exacerbation of Schizophrenia: Meta-Analysis of Randomized Placebo-Controlled Trials.
    J Clin Psychopharmacol. 2018;38:55-59.
    PubMed     Text format     Abstract available


  22. DYKEMA LR
    Abrupt Improvement in Obsessive-Compulsive Symptoms Upon Discontinuation of Clozapine.
    J Clin Psychopharmacol. 2018;38:88-89.
    PubMed     Text format    


    December 2017
  23. LIMOSIN F, Belhadi D, Comet D, Pacou M, et al
    Comparison of Paliperidone Palmitate and Risperidone Long-Acting Injection in Schizophrenic Patients: Results From a Multicenter Retrospective Cohort Study in France.
    J Clin Psychopharmacol. 2017 Dec 11. doi: 10.1097/JCP.0000000000000827.
    PubMed     Text format     Abstract available


  24. COLLE R, Boichot F, Bouteiller E, Elie-Lefebvre C, et al
    Restless Legs Syndrome and Schizophrenia: A Case Report.
    J Clin Psychopharmacol. 2017 Dec 6. doi: 10.1097/JCP.0000000000000832.
    PubMed     Text format    


    November 2017
  25. ALY EL-GABRY DM, Abdel Aziz K, Okasha T, Azzam H, et al
    Antipsychotic Polypharmacy and Its Relation to Metabolic Syndrome in Patients With Schizophrenia: An Egyptian Study.
    J Clin Psychopharmacol. 2017 Nov 28. doi: 10.1097/JCP.0000000000000815.
    PubMed     Text format     Abstract available


    October 2017
  26. SANDERS LLO, Menezes CES, Chaves Filho AJM, Viana GA, et al
    alpha-Lipoic Acid as Adjunctive Treatment for Schizophrenia: An Open-Label Trial.
    J Clin Psychopharmacol. 2017 Oct 19. doi: 10.1097/JCP.0000000000000800.
    PubMed     Text format     Abstract available


  27. JOY G, Whiskey E, Bolstridge M, Porras-Segovia A, et al
    Hearts and Minds: Real-Life Cardiotoxicity With Clozapine in Psychosis.
    J Clin Psychopharmacol. 2017 Oct 19. doi: 10.1097/JCP.0000000000000792.
    PubMed     Text format     Abstract available


  28. FEELEY RJ, Arnaout B, Yoon G
    Effective Switch From Clozapine to Aripiprazole in Treatment-Resistant Schizophrenia and Comorbid Alcohol Use Disorder.
    J Clin Psychopharmacol. 2017 Oct 12. doi: 10.1097/JCP.0000000000000794.
    PubMed     Text format    


  29. NAVKHARE P, Kalra G, Saddichha S
    Possible Psychosis Associated With Buprenorphine Withdrawal.
    J Clin Psychopharmacol. 2017 Oct 9. doi: 10.1097/JCP.0000000000000803.
    PubMed     Text format    


  30. ANG MS, Abdul Rashid NA, Lam M, Rapisarda A, et al
    The Impact of Medication Anticholinergic Burden on Cognitive Performance in People With Schizophrenia.
    J Clin Psychopharmacol. 2017 Oct 9. doi: 10.1097/JCP.0000000000000790.
    PubMed     Text format     Abstract available


  31. BERESFORD T, Buchanan J, Thumm EB, Emrick C, et al
    Late Reduction of Cocaine Cravings in a Randomized, Double-Blind Trial of Aripiprazole vs Perphenazine in Schizophrenia and Comorbid Cocaine Dependence.
    J Clin Psychopharmacol. 2017 Oct 3. doi: 10.1097/JCP.0000000000000789.
    PubMed     Text format     Abstract available


    September 2017
  32. SAJATOVIC M, Ramirez LF, Fuentes-Casiano E, Cage J, et al
    A 6-Month Prospective Trial of a Personalized Behavioral Intervention + Long-Acting Injectable Antipsychotic in Individuals With Schizophrenia at Risk of Treatment Nonadherence and Homelessness.
    J Clin Psychopharmacol. 2017 Sep 19. doi: 10.1097/JCP.0000000000000778.
    PubMed     Text format     Abstract available


  33. HOJLUND M, Munk-Jorgensen P
    Differences in Antipsychotic Prescriptions Between Centers in Young Outpatients With Schizophrenia.
    J Clin Psychopharmacol. 2017 Sep 7. doi: 10.1097/JCP.0000000000000779.
    PubMed     Text format    


    August 2017
  34. ZABALA A, Bustillo M, Querejeta I, Alonso M, et al
    A Pilot Study of the Usefulness of a Single Olanzapine Plasma Concentration as an Indicator of Early Drug Effect in a Small Sample of First-Episode Psychosis Patients.
    J Clin Psychopharmacol. 2017 Aug 8. doi: 10.1097/JCP.0000000000000770.
    PubMed     Text format     Abstract available


    June 2017
  35. DOYLE R, Behan C, O'Keeffe D, Masterson S, et al
    Clozapine Use in a Cohort of First-Episode Psychosis.
    J Clin Psychopharmacol. 2017 Jun 23. doi: 10.1097/JCP.0000000000000734.
    PubMed     Text format     Abstract available


  36. SHE S, Yi W, Zhang B, Zheng Y, et al
    Worsening of Myasthenia Gravis After Administration of Antipsychotics for Treatment of Schizophrenia: A Case Report and Review of Literature.
    J Clin Psychopharmacol. 2017 Jun 20. doi: 10.1097/JCP.0000000000000741.
    PubMed     Text format    


  37. SHAO W, Brown T, Ayub S
    Phenelzine Withdrawal-Associated Psychosis and Mania.
    J Clin Psychopharmacol. 2017 Jun 13. doi: 10.1097/JCP.0000000000000739.
    PubMed     Text format    


  38. BRUNO A, Pandolfo G, Crucitti M, Cedro C, et al
    Bergamot Polyphenolic Fraction Supplementation Improves Cognitive Functioning in Schizophrenia: Data From an 8-Week, Open-Label Pilot Study.
    J Clin Psychopharmacol. 2017 Jun 6. doi: 10.1097/JCP.0000000000000730.
    PubMed     Text format     Abstract available


  39. BARMAN R, Kumar S, Pagadala B, Detweiler MB, et al
    Cocaine Abuse, Traumatic Brain Injury, and Preexisting Brain Lesions as Risk Factors for Bupropion-Associated Psychosis.
    J Clin Psychopharmacol. 2017 Jun 5. doi: 10.1097/JCP.0000000000000729.
    PubMed     Text format     Abstract available


  40. WATANABE J, Fukui N, Suzuki Y, Sugai T, et al
    Effect of GWAS-Identified Genetic Variants on Maximum QT Interval in Patients With Schizophrenia Receiving Antipsychotic Agents: A 24-Hour Holter ECG Study.
    J Clin Psychopharmacol. 2017 Jun 5. doi: 10.1097/JCP.0000000000000724.
    PubMed     Text format     Abstract available


  41. KANTROWITZ JT, Nolan KA, Epstein ML, Lehrfeld N, et al
    Neurophysiological Effects of Bitopertin in Schizophrenia.
    J Clin Psychopharmacol. 2017 Jun 5. doi: 10.1097/JCP.0000000000000722.
    PubMed     Text format     Abstract available


  42. BUCHANAN RW, Kelly DL, Weiner E, Gold JM, et al
    A Randomized Clinical Trial of Oxytocin or Galantamine for the Treatment of Negative Symptoms and Cognitive Impairments in People With Schizophrenia.
    J Clin Psychopharmacol. 2017 Jun 5. doi: 10.1097/JCP.0000000000000720.
    PubMed     Text format     Abstract available


  43. ZHENG W, Wang S, Ungvari GS, Ng CH, et al
    Amantadine for Antipsychotic-Related Weight Gain: Meta-Analysis of Randomized Placebo-Controlled Trials.
    J Clin Psychopharmacol. 2017;37:341-346.
    PubMed     Text format     Abstract available


  44. LOPEZ LV, Shaikh A, Merson J, Greenberg J, et al
    Accuracy of Clinician Assessments of Medication Status in the Emergency Setting: A Comparison of Clinician Assessment of Antipsychotic Usage and Plasma Level Determination.
    J Clin Psychopharmacol. 2017;37:310-314.
    PubMed     Text format     Abstract available


    April 2017
  45. ISMAIL Z, Peters-Strickland T, Miguelez M, Baker RA, et al
    Aripiprazole Once-Monthly in the Treatment of Acute Psychotic Episodes in Schizophrenia: Post Hoc Analysis of Positive and Negative Syndrome Scale Marder Factor Scores.
    J Clin Psychopharmacol. 2017 Apr 5. doi: 10.1097/JCP.0000000000000710.
    PubMed     Text format     Abstract available


  46. KOHLER-FORSBERG O, Horsdal HT, Legge SE, MacCabe JH, et al
    Predictors of Nonhospitalization and Functional Response in Clozapine Treatment: A Nationwide, Population-Based Cohort Study.
    J Clin Psychopharmacol. 2017;37:148-154.
    PubMed     Text format     Abstract available


    March 2017
  47. HARD ML, Mills RJ, Sadler BM, Turncliff RZ, et al
    Aripiprazole Lauroxil: Pharmacokinetic Profile of This Long-Acting Injectable Antipsychotic in Persons With Schizophrenia.
    J Clin Psychopharmacol. 2017 Mar 27. doi: 10.1097/JCP.0000000000000691.
    PubMed     Text format     Abstract available


  48. GAHR M, Hiemke C, Connemann BJ, Schonfeldt-Lecuona C, et al
    First-Episode Psychosis Possibly due to Roxithromycin-Related Inhibition of Metabolization of Tetrahydrocannabinol.
    J Clin Psychopharmacol. 2017 Mar 21. doi: 10.1097/JCP.0000000000000707.
    PubMed     Text format    


  49. LIN CH, Lane HY
    Clotiapine Monotherapy in a Patient With Clozapine-Resistant Schizophrenia.
    J Clin Psychopharmacol. 2017 Mar 21. doi: 10.1097/JCP.0000000000000692.
    PubMed     Text format    


    February 2017
  50. LOOK ML, Boo YL, Chin PW, Hoo FK, et al
    Risperidone-Associated Rhabdomyolysis Without Neuroleptic Malignant Syndrome: A Case Report.
    J Clin Psychopharmacol. 2017;37:105-106.
    PubMed     Text format    


  51. GOTO T, Kato M, Matsumura Y, Omata N, et al
    Scopolamine Ointment for Clozapine-Associated Sialorrhea: A Case Report.
    J Clin Psychopharmacol. 2017;37:106-107.
    PubMed     Text format    


    October 2016
  52. STRUBE W, Kirsch B, Padberg F, Hasan A, et al
    Transcranial Direct Current Stimulation as Monotherapy for the Treatment of Auditory Hallucinations During Pregnancy: A Case Report.
    J Clin Psychopharmacol. 2016;36:534-5.
    PubMed     Text format    


  53. BUZINA N, Eterovic M
    Life-Threatening Lupus-Like Syndrome Associated With Clozapine.
    J Clin Psychopharmacol. 2016;36:532-4.
    PubMed     Text format    


  54. JAKOBSEN KD, Bruhn CH, Pagsberg AK, Fink-Jensen A, et al
    Neurological, Metabolic, and Psychiatric Adverse Events in Children and Adolescents Treated With Aripiprazole.
    J Clin Psychopharmacol. 2016;36:496-9.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Schizophrenia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: